How MCP Can Break Down Data Silos and Improve Collaboration in Pharma and Medical Device R&D

Data silos slow pharma and medical device R&D, causing inefficiencies and errors. The Model Context Protocol (MCP) enables AI systems to access and integrate data across departments securely, breaking silos, streamlining workflows, and accelerating research and decision-making. Early adoption of MCP is essential for faster, smarter, and more collaborative R&D.

The Challenge of Data Silos in Pharma and Medical Device R&D

Pharma and medical device companies accumulate vast amounts of data from labs, clinical trials, and operations, but much of it remains locked in departmental silos. It's like multiple chefs sharing a kitchen, but each has their own pantry and recipe book, with no common way to share ingredients or results. The result is slow, error-prone R&D. Teams can't easily find or trust all relevant information, so decisions are made on incomplete data and efforts are duplicated or wasted. In one anecdote, a researcher wasted months on an experiment because a colleague on his own floor had already done the same work without his knowledge.

This problem is widespread. When teams can't easily share information, decision-makers face blind spots that lead to errors and wasted resources. Breaking down these barriers is essential. Unified access to data can accelerate discovery, reduce duplicative work, and make AI tools usable across the organization.

What Is the Model Context Protocol (MCP)?

The Model Context Protocol (MCP) is an open standard (introduced by Anthropic in 2024) that lets AI systems connect on-the-fly to external data sources and tools. Think of it as the new HTTP for AI agents. It provides a single, uniform way for AI assistants to retrieve data. In practical terms, any database, instrument, or software can publish an MCP endpoint, and any AI model (ChatGPT, Claude, or a custom model) can discover and call it.

Under the hood, an MCP server exposes its capabilities (for example, functions to search an electronic lab notebook or retrieve patient records) in a self-describing format. An AI client first asks the server, "What can you do?" and the server lists available tools (function names, inputs, outputs). The AI then selects the appropriate function and calls it with the necessary parameters. This lets the model integrate new data sources without custom code. MCP is designed for security and governance: it provides a standardized way for AI systems to connect with external data sources and services in a secure, controlled manner. In short, MCP improves AI assistants from passive Q&A systems into active agents that can query and manipulate your data systems in a controlled way.

How MCP Works (Simply Explained)

Under the hood, MCP follows a client, server model. The AI application acts as the MCP client. It sends a request to an MCP server (which is a wrapped data source) asking, "What can you do?" The server replies with a list of tools or functions, each described by its name, expected inputs, and outputs. For example, the list might include functions like search_experiments(term, date_range) or get_patient_records(id).

Once the AI sees these options, it chooses the right tool for the task. Suppose a scientist asks, "What clinical trials involve drug X?" The AI might decide to call the server's search_trials(drug=X) function. The server runs that query and returns structured results (often as JSON). The AI then uses the returned data to form its answer. In other words, the AI doesn't just guess or rely on outdated training data; it directly invokes your live data systems and uses the exact data and logic you've provided.

Figure: A schematic of how the Model Context Protocol (MCP) connects an AI host to multiple data servers. Each MCP server wraps a specific resource (on-premise or cloud) and exposes it through a standard interface.

Compared to traditional APIs, MCP is more flexible. If a data provider updates its tools (for example, adds a new query parameter), an MCP server simply advertises the new options on the next client request. The AI adapts automatically without code changes. This dynamic approach lets AI assistants tap fresh data and tools as soon as they are available, greatly speeding up development. In sum, MCP turns any data service into an AI-ready extension: models can treat your data functions as if they were part of their own "brain," calling them as needed.

At the same time, another class of specialized tools is gaining traction in the pharma and medical devices sector. Atlas, for instance, is relied on by leading pharmaceutical companies for its database of 30,000+ FDA Form 483s and EIRs, 11,828 warning letters, 700,000+ inspections since 2010, 6,000+ investigator reports, and supply chain monitoring. What makes it stand out is the AI copilot that turns dense regulatory language into actionable answers in any language, plus custom analytics that help quality teams detect risks earlier, benchmark against peers, and prepare for inspections. MCP provides a universal protocol for connecting AI to data. Platforms like Atlas show how domain-specific solutions can layer deep regulatory intelligence on top.

How MCP Dismantles Data Silos

By giving AI a unified access layer, MCP effectively breaks down research silos. Organizations can wrap each data source (ELN, LIMS, clinical database, publication repository, etc.) in an MCP server, and then AI agents see them all through the same lens. The benefits include:

• Unified Data Access: AI models can query multiple data repositories through one interface. For example, GenomOncology's open-source BioMCP lets an AI assistant search cancer trial records, genomics datasets, and medical literature all at once. Likewise, an MCP server for the Open Targets Platform exposes rich gene, disease and drug, target data. Instead of manually linking these sources, an AI agent can ask a single question and get integrated answers drawn from each dataset.
• Cross-Department Collaboration: When silos speak the same language, teams share insights effortlessly. An AI agent with MCP access can pull data from lab notebooks, quality management systems, and manufacturing records in one flow. For example, a model could do near-real-time "quality checks" by comparing experimental results against regulatory standards, since MCP can connect both R&D and compliance systems. In practice, this means no department has to hand off reports manually, everyone works from the same up-to-date data.
• Streamlined Workflows: MCP automates many routine tasks that used to be manual. What once took days of cross-department handoffs can happen in seconds. In one pilot, an Open Targets MCP server was integrated into a discovery bot so it could fetch relevant target biology data automatically during analysis. Well-designed MCP servers act like plug-and-play modules: once you publish an interface, any AI agent can immediately call it. This accelerates tasks like data gathering, hypothesis testing, and report generation.

Figure: An AI assistant (Claude) using an Open Targets MCP server. The user asks a biomedical question, the AI calls multiple MCP-exposed functions behind the scenes, and then returns a concise answer with data from the Open Targets knowledge base.

• Enhanced Data Governance: MCP makes data access explicit and auditable. Every function an AI agent can call is defined up front, and each call can be logged. In practice, this means AI-driven actions are as traceable as any enterprise transaction. Companies should treat MCP endpoints like "systems of record," with version control, access reviews, and audit logs. For example, an MCP server can tag each tool or dataset by sensitivity (PHI, proprietary research, etc.) and enforce appropriate access controls. In short, MCP forces AI access to go through well-defined gates.

In summary, MCP lets AI models bridge formerly isolated systems. Rather than piecing together data by hand, researchers can rely on an AI assistant that sees all approved data sources as one unified knowledge base. This accelerates cross-functional projects, speeds up decision-making, and ensures everyone works from the same, up-to-date information.

Real-World MCP Applications in Pharma and Medical Devices

Several pioneering projects show how MCP is already reshaping pharma and medical device workflows:

• BioMCP (GenomOncology): In April 2025, GenomOncology released BioMCP, the first open-source MCP toolkit for biomedical data. BioMCP uses the Anthropic standard to connect AI to specialized medical databases. It supports "advanced searching and full-text retrieval" from oncology clinical trial registries, genomic datasets, and research publications. Crucially, the AI using BioMCP can refine queries conversationally: as GenomOncology's CTO explains, the agent can start with a broad disease question and then delve into related trials and genetic factors, with the system "remembering everything" previously discussed.
• Open Targets Platform: The Open Targets project provides curated data on gene, disease associations and drug targets. In mid-2025, a community engineer built an MCP server for this platform. This wraps the Open Targets API into dozens of callable functions. In one demonstration, a researcher simply plugged this MCP connector into a chat interface, asked about a disease like schizophrenia, and received a structured answer listing the top associated genes. This showed that even non-technical users can harness complex genomics data via MCP without writing code.

These examples highlight that MCP isn't just a theory, it's already delivering real insights. By turning specialized databases into AI-readable tools, projects like BioMCP and the Open Targets MCP server are giving scientists conversational access to data that used to require expert queries. As more datasets are exposed via MCP, AI tools will grow smarter and more reliable, because their answers come directly from authoritative sources.

Adoption and Ecosystem Growth

The MCP ecosystem has expanded rapidly in 2025, with clear indicators of mainstream adoption:

• Explosive Server Growth: By mid-2025, thousands of MCP servers were online. Anthropic's official directory listed over 5,800 servers by June (up from roughly 100 at the end of 2024. These include community-built connectors and official vendor services, reflecting global interest in the standard.
• Major Industry Support: All the big AI and cloud companies now back MCP. For example, OpenAI added MCP to ChatGPT, Google integrated it into its Gemini AI, and Microsoft built it into Copilot Studio. Even cloud infrastructure vendors offer hosted MCP endpoints. In short, MCP is becoming a standard feature in AI platforms, which means pharma and medical devices firms can adopt it knowing the tech ecosystem is ready.
• Pharma and Medical Device Readiness: The pharma and medical devices IT ecosystem is already preparing for MCP adoption. Centralized data platforms, ELN/LIMS providers, and cloud database vendors are beginning to introduce MCP-compatible features. These platforms are designed to consolidate siloed data into unified environments, which is exactly what MCP needs to operate effectively. Once data is centralized, an MCP layer makes it instantly available to AI-driven applications. Vendors across the sector are moving in this direction: electronic lab notebook (ELN) tools are starting to expose MCP endpoints, cloud providers are experimenting with native connectors, and compliance software is being adapted to support MCP integration. This signals a growing awareness in the industry that standardized, AI-ready access to research data will soon be a competitive necessity rather than a nice-to-have.
• Market Outlook: Analysts project large and growing AI value in pharmaceutical R&D. MCP will be a key enabler because it allows AI to reach all relevant data. With thousands of connectors live and top vendors on board, MCP looks poised to become the default enterprise data layer for AI in pharma and medical devices.

In summary, MCP adoption is no longer hypothetical. Thousands of servers exist, major vendors support it, and pharma and medical devices IT platforms are aligning to use it. Companies that adopt MCP now will have a head start in deploying AI across their data assets.

Future Impact on Innovation and AI

Looking ahead, MCP's impact on pharma and medical devices R&D promises to be profound:

• Faster Drug Discovery: By letting AI agents synthesize chemistry, biology, and clinical data instantly, MCP can dramatically shorten R&D cycles. For example, an AI design tool might propose a new molecule and immediately consult toxicity databases, pathway models, and patient data (all via MCP) before iterating. This near-real-time feedback loop means researchers can test and refine candidates much faster. In effect, AI agents could "know" the latest lab results and literature when evaluating each idea, helping teams catch promising leads earlier.
• Agentic AI in the Lab: MCP lays the groundwork for autonomous AI workflows. Imagine telling an AI: "Analyze last week's experiments and suggest next steps." The AI would use MCP to retrieve raw data from LIMS, run analytics, and report back. It could even schedule experiments or order reagents by interacting with inventory systems via MCP. In other words, MCP turns AI into a practical lab assistant, letting it drive complex processes with minimal human handholding.
• Advanced AI & Compliance: MCP also enables advanced, multi-modal AI. Future models could blend text, image, and structured data by calling MCP servers for each modality. For example, a pathology AI could fetch relevant microscopy images and genetic profiles on the fly. Importantly, healthcare-specific MCP extensions (sometimes called "HMCP") are being developed with compliance built in: they use secure authentication, encryption, and audit logging to meet HIPAA and GxP standards. This means powerful AI-driven analysis can be done in a controlled, auditable way.
• Strategic Advantage: Early adopters will gain a significant edge. Using MCP to integrate data feeds means faster innovation and more agile decision-making. In a data-rich field like pharmaceuticals, being able to use every piece of information via AI is a clear competitive differentiator. Firms that build MCP pipelines now will be positioned to lead the coming AI-driven wave of discovery.

MCP is more than a technical protocol. It's a strategic enabler for modern R&D. By connecting data, it lets scientists develop medicines more efficiently.